Highline Wealth Partners LLC Invests $30,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Highline Wealth Partners LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 205 shares of the financial services provider’s stock, valued at approximately $30,000.

A number of other institutional investors also recently modified their holdings of IBB. SeaCrest Wealth Management LLC raised its position in shares of iShares Biotechnology ETF by 4.8% during the first quarter. SeaCrest Wealth Management LLC now owns 3,503 shares of the financial services provider’s stock worth $481,000 after purchasing an additional 159 shares during the period. Ashton Thomas Private Wealth LLC lifted its stake in iShares Biotechnology ETF by 50.9% during the 1st quarter. Ashton Thomas Private Wealth LLC now owns 5,291 shares of the financial services provider’s stock valued at $726,000 after acquiring an additional 1,784 shares in the last quarter. SpiderRock Advisors LLC bought a new position in iShares Biotechnology ETF during the 1st quarter valued at $213,000. Sequoia Financial Advisors LLC lifted its stake in iShares Biotechnology ETF by 16.9% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,409 shares of the financial services provider’s stock valued at $331,000 after acquiring an additional 349 shares in the last quarter. Finally, Bray Capital Advisors lifted its stake in iShares Biotechnology ETF by 1.0% during the 1st quarter. Bray Capital Advisors now owns 18,856 shares of the financial services provider’s stock valued at $2,587,000 after acquiring an additional 180 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $142.41 on Thursday. The stock’s fifty day simple moving average is $145.24 and its two-hundred day simple moving average is $140.27. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.